RA
CL icon

Rise Advisors’s Colgate-Palmolive CL Stock Holding History

Rise Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-503
Closed -$40.2K – 352
2025
Q3 		$40.2K Sell
503
-25
-5% -$2.13K 0.01% 303
2025
Q2 		$48K Buy
528
+31
+6% +$2.83K 0.02% 244
2025
Q1 		$46.6K Buy
497
+67
+16% +$6K 0.02% 237
2024
Q4 		$39.1K Buy
430
+8
+2% +$763 0.02% 295
2024
Q3 		$43.8K Buy
422
+2
+0.5% +$204 0.02% 264
2024
Q2 		$40.8K Buy
420
+2
+0.5% +$184 0.02% 273
2024
Q1 		$37.6K Buy
+418
New +$35.4K 0.02% 301
2023
Q3 		– Sell
-8
Closed -$598 – 656
2023
Q2 		$632 Hold
8
– – ﹤0.01% 603
2023
Q1 		$612 Hold
8
– – ﹤0.01% 720
2022
Q4 		$638 Hold
8
– – ﹤0.01% 693
2022
Q3 		$1K Hold
8
– – ﹤0.01% 608
2022
Q2 		$1K Buy
+8
New +$626 ﹤0.01% 617

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rise Advisors's CL Position: Q4 2025 in Review

Rise Advisors sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 503 shares — an estimated $40.2K sold.

Rise Advisors first reported a position in CL in Q2 2022 and held it in 12 quarters. The position peaked at $48K in Q2 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Rise Advisors reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 503 Colgate-Palmolive shares in Q4 2025, an estimated $40.2K.
  • Rise Advisors first reported a position in Colgate-Palmolive in Q2 2022 and held it in 12 quarters.
  • Rise Advisors's Colgate-Palmolive position peaked at $48K in Q2 2025.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.